4.3 Article

Nuclear HER4 mediates acquired resistance to trastuzumab and is associated with poor outcome in HER2 positive breast cancer

Journal

Oncotarget
Volume 5, Issue 15, Pages -

Publisher

Impact Journals, LLC
DOI: 10.18632/oncotarget.1904

Keywords

-

Categories

-

Ask authors/readers for more resources

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.3
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available